Last $31.26 USD
Change Today +0.14 / 0.45%
Volume 209.5K
AUXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:02 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adrian Adams

Chief Executive Officer, President and Director, Auxilium Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 4 different organizations across 9 different industries.

See Board Relationships
63$4,148,160
As of Fiscal Year 2013

Background*

Mr. Adrian Adams has been the Chief Executive Officer and President for Auxilium Pharmaceuticals Inc. since December 8, 2011. Mr. Adams has over 30 years of experience in pharmaceutical executive leadership with a record of successfully building organizations, delivering successful results against short, medium and long-term goals and creating shareholder value. Mr. Adams served as the Chief Executive Officer of Neurologix Inc. from September 19, 2011 to November 30, ...

Read Full Background

Corporate Headquarters*

640 Lee Road
Chesterbrook, Pennsylvania 19087

United States

Phone: 484-321-5900
Fax: 484-321-5999

Board Members Memberships*

Former Chairman of the Board
2002-Present
Chief Executive Officer, President, Chief Operating Officer and Director
2005-2007
Former Director and Member of Compensation Committee
2007-Present
Director, Chairman of Compensation & Human Resources Committee and Member of Corporate Governance Committee
2007-2010
Former Chief Executive Officer, President and Executive Director
2010-N/A
Former Chief Executive Officer, President and Director
2011-2011
Former Chairman and Chief Executive Officer
2011-Present
Chief Executive Officer, President and Director
2013-Present
Chairman, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
University of Manchester
Unknown/Other Education
Salford University

Other Affiliations*

Annual Compensation*

Salary$666,154
Total Annual Compensation$666,154

Stock Options*

Restricted Stock Awards$1,496,068
All Other Compensation$5,151
Exercisable Options275,000
Exercisable Options Value$915,750
Unexercisable Options404,000
Unexercisable Options Value$1,273,080
Total Value of Options$2,188,830
Total Number of Options679,000

Total Compensation*

Total Annual Cash Compensation$1,542,305
Total Short Term Compensation$666,154
Other Long Term Compensation$1,501,219
Total Calculated Compensation$4,148,160
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AUXL:US $31.26 USD +0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Eamonn P. Hobbs Chief Executive Officer, President, Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee
Antares Pharma Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUXILIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.